(Q40431706)

20 September 2017

Treatment of multiple sclerosis: beyond the NICE guidelines (English)

1 reference

20 September 2017

0 references

A Chaudhuri

1

1 reference

PubMed ID

15820974

20 September 2017

P O Behan

series ordinal

2

1 reference

PubMed ID

15820974

20 September 2017

language of work or name

English

0 references

publication date

8 April 2005

1 reference

QJM: An International Journal of Medicine

20 September 2017

1 reference

20 September 2017

98

1 reference

20 September 2017

5

1 reference

20 September 2017

373-378

1 reference

Multiple sclerosis is not an autoimmune disease

20 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCI059

Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCI059

Interferons in relapsing remitting multiple sclerosis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCI059

Mitoxantrone trial in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCI059

Association studies in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCI059

Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCI059

Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCI059

Why we should offer routine vitamin D supplementation in pregnancy and childhood to prevent multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCI059

Vitamin D intake and incidence of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCI059

Cigarette smoking and incidence of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCI059

Oral simvastatin treatment in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCI059

Fatigue in neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCI059

Paroxysmal attacks in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCI059

Low-dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCI059

Treatment with acetazolamide of brain-stem and spinal paroxysmal disturbances in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCI059

Treatment of pathologic laughing and weeping with amitriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCI059

Major depression in multiple sclerosis: a population-based perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCI059

Multiple sclerosis: side effects of interferon beta therapy and their management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCI059

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCI059

Course of depression during the initiation of interferon beta-1a treatment for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCI059

Post-ECT increases in MRI regional T2 relaxation times and their relationship to cognitive side effects: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCI059

Multiple sclerosis and ECT: possible value of gadolinium-enhanced magnetic resonance scans for identifying high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCI059

Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCI059

Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCI059

Cognitive dysfunction in multiple sclerosis: natural history, pathophysiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCI059

Parent-of-origin effect in multiple sclerosis: observations in half-siblings

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCI059

21 January 2018

Identifiers

DOI

10.1093/QJMED/HCI059

1 reference

20 September 2017

1 reference

PubMed ID

15820974